Obstetrics & Gynecology Doctors in Davidson, NC Accepting Medicare

3 Obstetrics & Gynecology doctors found. Showing 1 - 3

Linda Bresnahan, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 2101 Shiloh Church Rd, Ste 202, Davidson, NC 28036 Phone: 704-439-3770

Hannah Hughes Ehasz, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 2101 Shiloh Church Rd, Ste 202, Davidson, NC 28036 Phone: 704-403-7800

Ariel Catherine Haddad, DO Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 2101 Shiloh Church Rd, Ste 202, Davidson, NC 28036 Phone: 704-403-7800

News Archive

Scientists identify new treatment to combat PFAPA syndrome in children

A preliminary study conducted by a team at the National Institutes of Health has identified a promising new treatment in children for the most common form of a rare disorder.

HIV-positive patients have shorter survival periods while awaiting liver transplants

A new study on HIV-positive patients eligible for liver transplants found that their survival while waiting for a transplant is significantly shorter than patients who are HIV-negative.

Study reveals potential markers for treating patients with metastatic clear cell RCC

Markers such as CA9, CD31, CD34 and VEGFR1/2 in the primary tumours might serve as predictors of a good response to a sunitinib treatment in patients with metastatic clear cell renal cell carcinoma (ccRCC), according to a new study to be presented at the 28th Annual EAU Congress currently on-going in Milan.

Study: High-dose blood thinners have no additional benefit in COVID-19 patients

While COVID-19 infected patients should be treated with standard anticoagulation therapies, such as blood thinning medication, a new study by researchers at the George Washington University (GW) shows that anticoagulating patients at higher doses, without traditional medical indications to do so, may be ineffective and even harmful.

Phase 2 pivotal trial of AC220 initiated by Ambit Biosciences

Ambit Biosciences Corporation announced today the enrollment and dosing at the University of Texas M. D. Anderson Cancer Center of the first patient in the ACE (AC220 Monotherapy Efficacy) Phase 2 pivotal trial in patients with relapsed or refractory acute myeloid leukemia (AML).

Read more Medical News

› Verified 3 days ago